Prostate Cancer and Wnt/Stat3 Signaling Publisher



Etemad S¹ ; Manavi MS² ; Varnousafaderani MHH³ ; Faghihkhorasani F⁴ ; Ghaderi H⁵ ; Kordmahalleh SE⁶ ; Ebrahimi N⁷ ; Hajifatahaliha M⁸ ; Aref AR^{9, 10}
Source: Prostate Cancer: Molecular Events and Therapeutic Modalities Published:2024

Abstract

Globally, prostate cancer remains a major health problem, needing a thorough knowledge of the underlying molecular processes that govern its develop ment. In this chapter, we dig into the complex functions of the Wnt and STAT3 signaling pathways in prostate cancer, illuminating their involvement in the pro gression and metastasis of the illness. The WNT and STAT3 signaling pathways are thoroughly discussed at the beginning of the chapter, emphasizing both their critical roles in healthy cellular activities and the dysregulation of these pathways in prostate cancer. Both routes are known to exert substantial influence on cellular growth, survival, migration, and differentiation during carcinogenesis. In addition, we investigate the crucial yet unresolved interaction among the WNT and STAT3 pathways in prostate cancer. Understanding the complex regulatory mechanisms driving prostate cancer growth may be revealed by examining the molecular and cellular interactions between different pathways. The potential of WNT and STAT3 as therapeutic targets in the treatment of prostate cancer is covered in great detail in this chapter. Targeting these pathways presents interesting opportunities for creating tailored therapeutics intended to slow disease progression and enhance patient outcomes due to their significant roles in tumor formation and metastasis. The importance of the WNT and STAT3 signaling pathways in prostate cancer and their value as possible therapeutic targets are highlighted in Chap. 6's conclusion. It may be possible to develop efficient precision medicines for patients with prostate cancer by better understanding their interactions and focusing on these pathways, thereby advancing oncology and enhancing clinical outcomes. © The Author(s). All rights reserved.